APYX · Apyx Medical Corp · Insider Trading

Held by a Spousal Lifetime Access Trust (the "SLAT"). The Reporting Person's spouse and children are trustees of the SLAT. The Reporting Person disclaims beneficial ownership of all securities held by the SLAT, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein, if any.

On June 30, 2026, the Reporting Person effected a net exercise of 12,000 stock options with an exercise price of $1.88 per share. Pursuant to the terms of the exercise, 5,024 shares otherwise issuable upon exercise were withheld by the issuer at a value of $4.49 per share to satisfy the aggregate exercise price, resulting in the issuance of 6,976 net shares to the Reporting Person.

Held by a Spousal Lifetime Access Trust (the "SLAT"). The Reporting Person's spouse and children are trustees of the SLAT. The Reporting Person disclaims beneficial ownership of all securities held by the SLAT, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein, if any.

Held by a Spousal Lifetime Access Trust (the "SLAT"). The Reporting Person's spouse and children are trustees of the SLAT. The Reporting Person disclaims beneficial ownership of all securities held by the SLAT, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein, if any.

Held by The Roman Family Revocable Trust of which Reporting Person is both a trustee and beneficiary.

On June 15, 2026, the Reporting Person effected a net exercise of 15,000 stock options with an exercise price of $3.23 per share. Pursuant to the terms of the exercise, 10,533 shares otherwise issuable upon exercise were withheld by the issuer at a value of $4.60 per share to satisfy the aggregate exercise price, resulting in the issuance of 4,467 net shares to the Reporting Person.

Held by The Roman Family Revocable Trust of which Reporting Person is both a trustee and beneficiary.

Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.

The restricted stock units vest as follows: (i) 150,000 restricted stock units vest immediately on June 11, 2026 (the "Grant Date"); (ii) 150,000 restricted stock units will commence vesting on the first anniversary of the Grant Date and will vest ratably over the twelve (12) month period beginning on such date; and (iii) 150,000 restricted stock units will commence vesting on the second anniversary of the Grant Date and will vest ratably over the twelve (12) month period beginning on such date, in each case subject to the Reporting Person's continued service through each applicable vesting date and the terms and conditions of the applicable award agreement.

Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.

Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.

Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.

Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.

Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.

Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.

On March 15, 2026, the Reporting Person exercised his stock option awarded on March 16, 2016, to purchase 37,000 shares of the Issuer's common stock at a price of $1.80 per share pursuant to Issuer's 2015 Share Incentive Plan.

Held by The Roman Family Revocable Trust of which Reporting Person is both a trustee and beneficiary.

On January 27, 2026, the Reporting Person exercised his stock option awarded on March 16, 2016, to purchase 12,000 shares of the Issuer's common stock at a price of $1.80 per share pursuant to Issuer's 2015 Share Incentive Plan.

Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.

Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.

Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.

Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.

Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.

Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.

Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.

Reporting person was granted a stock option which shall vest ratably over a thirty-six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.

Reporting person was granted a stock option which shall vest ratably over a thirty-six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.

Issued pursuant to the Issuer's Director Compensation Program, as amended, which provides for the issuance of a stock option to non-employee directors with an exercise price equal to the closing price of the Issuer's common stock on its principal exchange on the second trading day following the Issuer's release of its preliminary 2024 revenue. The option vests ratably over a 12-month period and becomes fully vested and exercisable on the first anniversary of the date of grant.

Issued pursuant to the Issuer's Director Compensation Program, as amended, which provides for the issuance of a stock option to non-employee directors with an exercise price equal to the closing price of the Issuer's common stock on its principal exchange on the second trading day following the Issuer's release of its preliminary 2024 revenue. The option vests ratably over a 12-month period and becomes fully vested and exercisable on the first anniversary of the date of grant.

Reporting person was granted a stock option which shall vest ratably over a thirty-six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.

Issued pursuant to the Issuer's Director Compensation Program, as amended, which provides for the issuance of a stock option to non-employee directors with an exercise price equal to the closing price of the Issuer's common stock on its principal exchange on the second trading day following the Issuer's release of its preliminary 2024 revenue. The option vests ratably over a 12-month period and becomes fully vested and exercisable on the first anniversary of the date of grant.

Issued pursuant to the Issuer's Director Compensation Program, as amended, which provides for the issuance of a stock option to non-employee directors with an exercise price equal to the closing price of the Issuer's common stock on its principal exchange on the second trading day following the Issuer's release of its preliminary 2024 revenue. The option vests ratably over a 12-month period and becomes fully vested and exercisable on the first anniversary of the date of grant.

Reporting person was granted a stock option which shall vest ratably over a thirty-six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.

Reflects the addition of 664 shares that were inadvertently omitted from the Reporting Person's original Form 4.

This transaction was executed in multiple trades at prices ranging from $1.12 to $1.13. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

Issued pursuant to the Issuer's Director Compensation Program as set forth in the Issuer's definitive proxy statement filed with the U.S. Securities and Exchange Commission on June 25, 2024, which provides for the issuance of a stock option to non-employee directors on the date of the Issuer's Annual Meeting of Stockholders. The option vests ratably over a 12-month period and becomes fully vested and exercisable on the first anniversary of the date of grant.

Issued pursuant to the Issuer's Director Compensation Program as set forth in the Issuer's definitive proxy statement filed with the U.S. Securities and Exchange Commission on June 25, 2024, which provides for the issuance of a stock option to non-employee directors on the date of the Issuer's Annual Meeting of Stockholders. The option vests ratably over a 12-month period and becomes fully vested and exercisable on the first anniversary of the date of grant.

Issued pursuant to the Issuer's Director Compensation Program as set forth in the Issuer's definitive proxy statement filed with the U.S. Securities and Exchange Commission on June 25, 2024, which provides for the issuance of a stock option to non-employee directors on the date of the Issuer's Annual Meeting of Stockholders. The option vests ratably over a 12-month period and becomes fully vested and exercisable on the first anniversary of the date of grant.

Issued pursuant to the Issuer's Director Compensation Program as set forth in the Issuer's definitive proxy statement filed with the U.S. Securities and Exchange Commission on June 25, 2024, which provides for the issuance of a stock option to non-employee directors on the date of the Issuer's Annual Meeting of Stockholders. The option vests ratably over a 12-month period and becomes fully vested and exercisable on the first anniversary of the date of grant.

Issued pursuant to the Issuer's Director Compensation Program as set forth in the Issuer's definitive proxy statement filed with the U.S. Securities and Exchange Commission on June 25, 2024, which provides for the issuance of a stock option to non-employee directors on the date of the Issuer's Annual Meeting of Stockholders. The option vests ratably over a 12-month period and becomes fully vested and exercisable on the first anniversary of the date of grant.

Issued pursuant to the Issuer's Director Compensation Program as set forth in the Issuer's definitive proxy statement filed with the U.S. Securities and Exchange Commission on June 25, 2024, which provides for the issuance of a stock option to non-employee directors on the date of the Issuer's Annual Meeting of Stockholders. The option vests ratably over a 12-month period and becomes fully vested and exercisable on the first anniversary of the date of grant.

Issued pursuant to the Issuer's Director Compensation Program as set forth in the Issuer's definitive proxy statement filed with the U.S. Securities and Exchange Commission on June 25, 2024, which provides for the issuance of a stock option to non-employee directors on the date of the Issuer's Annual Meeting of Stockholders. The option vests ratably over a 12-month period and becomes fully vested and exercisable on the first anniversary of the date of grant.

Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.

Reporting person was granted a stock option which shall vest ratably in two equal installments on December 4, 2025 and December 4, 2026.

Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.

Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.

This transaction was executed in multiple trades at prices ranging from $2.14 to $2.22. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

This transaction was executed in multiple trades at a prices ranging from $1.56 to $1.57. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.

Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.

Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.